Abiopharma

📋 Meisner Derek M (Officer) plans to sell 9K shares of Acumen Pharmaceuticals, Inc. (at $1.71 each, total $15K) Filed: Jan 12, 2026 | ID: 000034

Borthwick Kathleen 🟡 adjusted position in 2.1K shares (1 derivative) of Passage BIO, Inc. (PASG) at $18.44 Transaction Date: Jan 08, 2026 | Filing ID: 000001

📋 OConnell Daniel Joseph (Officer) plans to sell 5K shares of Acumen Pharmaceuticals, Inc. (at $1.73 each, total $9K) Filed: Jan 12, 2026 | ID: 000033

Rubenstein Robert 🟢 acquired 75.0K shares of HYPERION DEFI, INC. (HYPD) Transaction Date: Jan 12, 2026 | Filing ID: 002860

SciSparc Notification (SPRC)

New Form 10-K - Anixa Biosciences Inc Filed: 2026-01-12 AccNo: 0001493152-26-001845 Size: 5 MB

SciSparc Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance

New Form SCHEDULE 13G - Galecto, Inc. Filed: 2026-01-12 AccNo: 0001193125-26-010344 Size: 8 KB

New Form 3 - HYPERION DEFI, INC. Filed: 2026-01-12 AccNo: 0001104659-26-002857 Size: 9 KB

Anand Bhaskar 🟢 acquired 30.0K shares (1 derivative) of Summit Therapeutics Inc. (SMMT) at $18.83 Transaction Date: Jan 08, 2026 | Filing ID: 000003

Kavuru Vimal 🟢 acquired 10.0K shares (1 derivative) of Grace Therapeutics, Inc. (GRCE) at $3.80 Transaction Date: Jan 08, 2026 | Filing ID: 000969

Kottayil George 🟢 acquired 10.0K shares (1 derivative) of Grace Therapeutics, Inc. (GRCE) at $3.80 Transaction Date: Jan 08, 2026 | Filing ID: 000968

NEUGEBOREN EDWARD 🟢 acquired 10.0K shares (1 derivative) of Grace Therapeutics, Inc. (GRCE) at $3.80 Transaction Date: Jan 08, 2026 | Filing ID: 000967

DAVIS A BRIAN 🟢 acquired 10.0K shares (1 derivative) of Grace Therapeutics, Inc. (GRCE) at $3.80 Transaction Date: Jan 08, 2026 | Filing ID: 000966

(90% Positive) Atara Biotherapeutics Inc (ATRA) Announces Clinical Development Update